Your browser doesn't support javascript.
loading
Characterization of disease-propagating stem cells responsible for myeloproliferative neoplasm-blast phase.
Wang, Xiaoli; Rampal, Raajit K; Hu, Cing Siang; Tripodi, Joseph; Farnoud, Noushin; Petersen, Bruce; Rossi, Michael R; Patel, Minal; McGovern, Erin; Najfeld, Vesna; Iancu-Rubin, Camelia; Lu, Min; Davis, Andrew; Kremyanskaya, Marina; Weinberg, Rona Singer; Mascarenhas, John; Hoffman, Ronald.
Afiliación
  • Wang X; Division of Hematology/Medical Oncology/Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.
  • Rampal RK; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Hu CS; Division of Hematology/Medical Oncology/Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.
  • Tripodi J; Division of Hematology/Medical Oncology/Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.
  • Farnoud N; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Petersen B; Division of Hematology/Medical Oncology/Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.
  • Rossi MR; Genetics and Genomic Sciences, ISMMS, New York, New York.
  • Patel M; Sema4, Stamford, Connecticut, USA.
  • McGovern E; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Najfeld V; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Iancu-Rubin C; Division of Hematology/Medical Oncology/Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.
  • Lu M; Division of Hematology/Medical Oncology/Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.
  • Davis A; Division of Hematology/Medical Oncology/Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.
  • Kremyanskaya M; Division of Hematology/Medical Oncology/Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.
  • Weinberg RS; Division of Hematology/Medical Oncology/Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.
  • Mascarenhas J; New York Blood Center, New York, New York, USA.
  • Hoffman R; Division of Hematology/Medical Oncology/Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.
JCI Insight ; 7(8)2022 04 22.
Article en En | MEDLINE | ID: mdl-35259128
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Crisis Blástica / Trastornos Mieloproliferativos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: JCI Insight Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Crisis Blástica / Trastornos Mieloproliferativos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: JCI Insight Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos